Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus

Arthritis Care and Research

Volumn 64, Issue 9, 2012, Pages 1328-1333

  Murray, Sara G ^a   Yazdany, Jinoos ^a   Kaiser, Rachel ^a   Criswell, Lindsey A ^a   Trupin, Laura ^a   Yelin, Edward H ^a   Katz, Patricia P ^a   Julian, Laura J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITION; COGNITIVE DEFECT; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; SMOKING; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; VERBAL MEMORY;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; COGNITION; COGNITION DISORDERS; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; LOGISTIC MODELS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMORY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SAN FRANCISCO; STROKE;

EID: 84865581225     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21691     Document Type: Article

References (38)

1. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A,. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001; 57: 496-500.
2. Hanly JG, Fisk JD, Sherwood G, Jones E, Jones JV, Eastwood B,. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992; 19: 562-7.
3. Tomietto P, Annese V, D'Agostini S, Venturini P, La Torre G, De Vita S, et al. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 2007; 57: 1461-72.
4. McLaurin EY, Holliday SL, Williams P, Brey RL,. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005; 64: 297-303.
5. Singh-Manoux A, Sabia S, Lajnef M, Ferrie JE, Nabi H, Britton AR, et al. History of coronary heart disease and cognitive performance in midlife: the Whitehall II study. Eur Heart J 2008; 29: 2100-7.
6. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42-8.
7. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408-15.
8. Ward MM,. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 338-46.
9. Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH,. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the Nurses' Health Study. Arthritis Rheum 2009; 61: 1396-402.
10. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
11. Yelin E, Trupin L, Katz P, Criswell L, Yazdany J, Gillis J, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 56-63.
12. Frank RM, Byrne GJ,. The clinical utility of the Hopkins Verbal Learning Test as a screening test for mild dementia. Int J Geriatr Psychiatry 2000; 15: 317-24.
13. Brandt J, Benedict RH,. Hopkins Verbal Learning Test-Revised. Lutz (FL): Psychological Assessment Resources; 2001.
14. Ruff RM, Light RH, Parker SB, Levin HS,. Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol 1996; 11: 329-38.
15. Gladsjo JA, Miller SW, Heaton R,. Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Lutz (FL): Psychological Assessment Resources; 1999.
16. Julian LJ, Yazdany J, Trupin L, Criswell LA, Yelin E, Katz PP,. Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2012; 64: 448-54.
17. Saczynski JS, Jonsdottir MK, Garcia ME, Jonsson PV, Peila R, Eiriksdottir G, et al. Cognitive impairment: an increasingly important complication of type 2 diabetes. The age, gene/environment susceptibility-Reykjavik study. Am J Epidemiol 2008; 168: 1132-9.
18. Murray AM, Pederson SL, Tupper DE, Hochhalter AK, Miller WA, Li Q, et al. Acute variation in cognitive function in hemodialysis patients: a cohort study with repeated measures. Am J Kidney Dis 2007; 50: 270-8.
19. Panopalis P, Julian L, Yazdany J, Gillis JZ, Trupin L, Hersh A, et al. Impact of memory impairment on employment status in persons with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 1453-60.
20. Karlson EW, Daltroy LH, Rivest C, Ramsey-Goldman R, Wright EA, Partridge AJ, et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus 2003; 12: 280-6.
21. Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP,. Validation of the Systemic Lupus Erythematosus Activity Questionnaire in a large observational cohort. Arthritis Rheum 2008; 59: 136-43.
22. Julian LJ, Gregorich SE, Tonner C, Yazdany J, Trupin L, Criswell LA, et al. Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011; 63: 884-90.
23. Radloff L,. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
24. Brady CB, Spiro A III, Gaziano JM,. Effects of age and hypertension status on cognition: the Veterans Affairs Normative Aging Study. Neuropsychology 2005; 19: 770-7.
25. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K,. Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension. J Hypertens 2008; 26: 1636-41.
26. Raz N, Rodrigue KM, Acker JD,. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. Behav Neurosci 2003; 117: 1169-80.
27. Mikdashi J, Handwerger B, Langenberg P, Miller M, Kittner S,. Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus. Stroke 2007; 38: 281-5.
28. Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A,. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 2009; 8: 998-1005.
29. Olazaran J, Lopez-Longo J, Cruz I, Bittini A, Carreno L,. Cognitive dysfunction in systemic lupus erythematosus: prevalence and correlates. Eur Neurol 2009; 62: 49-55.
30. Menon S, Jameson-Shortall E, Newman SP, Hall-Craggs MR, Chinn R, Isenberg DA,. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 735-41.
31. Tatemichi TK, Desmond DW, Stern Y, Paik M, Sano M, Bagiella E,. Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry 1994; 57: 202-7.
32. Patel MD, Coshall C, Rudd AG, Wolfe CD,. Cognitive impairment after stroke: clinical determinants and its associations with long-term stroke outcomes. J Am Geriatr Soc 2002; 50: 700-6.
33. Bobba RS, Johnson SR, Davis AM,. A review of the Sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome: where do the revised Sapporo criteria add value? J Rheumatol 2007; 34: 1522-7.
34. Reitz C, Schupf N, Luchsinger JA, Brickman AM, Manly JJ, Andrews H, et al. Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and whites. Arch Neurol 2009; 66: 834-40.
35. Vargas CM, Burt VL, Gillum RF, Pamuk ER,. Validity of self-reported hypertension in the National Health and Nutrition Examination Survey III, 1988-1991. Prev Med 1997; 26: 678-85.
36. Monastero R, Bettini P, Del Zotto E, Cottini E, Tincani A, Balestrieri G, et al. Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. J Neurol Sci 2001; 184: 33-9.
37. Leritz E, Brandt J, Minor M, Reis-Jensen F, Petri M,. "Subcortical" cognitive impairment in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 2000; 6: 821-5.
38. Julian LJ, Tonner C, Yelin E, Yazdany J, Trupin L, Criswell LA, et al. Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011; 63: 542-9.